There is a risk too many people are being diagnosed as obese when "a more accurate" and "nuanced" definition is needed, a report from global experts says. Doctors should consider the overall health of patients with excess fat,

Climate change has brought both fiercer rains and deeper droughts, leaving the city with brush like kindling—and the phenomenon is on the rise worldwide.

By Linda Naa Deide Aryeetey Accra, Jan 21 GNA- The 4th Global Non-Communicable Disease (NCD) Alliance Forum slated for February 13 to 15, is to be hosted in Kigali, Rwanda. This makes it the first time an African country will be hosting the strategic forum.

Maintaining a healthy weight is a vital element of self-care and plays a key role in promoting physical health and overall quality of life. Interestingly, majority of people (healthcare professionals included) often do not know how much they weigh at any particular point in time.

Ghanaians have been urged to reduce meat consumption to at least once a week for their well-being and to prevent Non-Communicable Diseases (NDCs).

The first study to assess how weight-loss drugs affect the whole of human health has discovered an "eye-opening" impact on the body, researchers say.

This article seems funny, though, but I am tempted to do this write-up due to the many female students I have seen who are glued to their gum.

New Insights Into the Biology and Risk Factors of Childhood Obesity Jan. 15, 2025 — A cutting-edge molecular approach provides a detailed picture of the biological pathways associated with ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...

VK-2735 is under clinical development by Viking Therapeutics and currently in Phase II for Obesity. According to GlobalData, Phase II drugs for Obesity have a 29% phase transition success rate (PTSR) indication benchmark for progressing into Phase III.

Mazdutide is under clinical development by Eli Lilly and Co and currently in Phase II for Obesity. According to GlobalData, Phase II drugs for Obesity have a 29% phase transition success rate (PTSR) indication benchmark for progressing into Phase III.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world